Abstract
This chapter describes the effects of some physico-chemical properties of polymer nanoparticles influencing the development of toxicological effects. More particularly, the effect of some parameters that may control the interaction of polymer nanoparticles with the biological environment (such as their composition, size, surface properties, and biodegradability) and, thus, be key factors of their efficacy and toxicity, is discussed. In addition, the chapter also reviews the toxicity results that have been found in the literature regarding the administration of polymer nanoparticles as delivery systems by different ways of administration including intravenous, oral, pulmonary, nasal, and ophthalmic routes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal R, Singh V, Jurney P, Shi L, Sreenivasan SV, Roy K (2013) Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. Proc Natl Acad Sci USA 110(43):17247–17252
Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61(6):428–437
Akhlaghi SP, Saremi S, Ostad SN, Dinarvand R, Atyabi F (2010) Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines. Nanomedicine 6(5):689–697
Al-Hanbali O, Rutt KJ, Sarker DK, Hunter AC, Moghimi SM (2006) Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption. J Nanosci Nanotechnol 6(9–10):3126–3133
Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W (2006) Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 111(1–2):107–116
Antunes F, Andrade F, Araujo F, Ferreira D, Sarmento S (2013) Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm 83(3):427–435
Arbos P, Wirth M, Arangoa MA, Gabor F, Irache JM (2002) Gantrez® AN as a new polymer for the preparation of ligand–nanoparticle conjugates. J Control Release 83(3):321–330
Asgharian B, Price OT (2007) Deposition of ultrafine (nano)particles in the human lung. Inhal Toxicol. 19(13):1045–1054
Aydın RS (2013) Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting. J Biomed Mater Res A 101(5):1405–1415
Azami S, Roa WH, Lobenberg R (2008) Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev 60(8):863–875
Barua S, Yoo JW, Kolhar P, Wakankar A, Gokarn YR, Mitragotri SI (2013) Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci USA 110(9):3270–3275
Bennett WD (2002) Rapid translocation of nanoparticles from the lung to the bloodstream? Am J Respir Crit Care Med 165(12):1671–1672
Bertholon I, Vauthier C, Labarre D (2006) Complement activation by core-shell poly(isobutylcyanoacrylate)–polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm Res 23(6):1313–1323
Bhardwaj V, Ankola DD, Gupta SC, Schneider M, Lehr CM, Ravi Kumar MNV (2009) PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. Pharm Res 26(11):2495–2503
Brown DM, Kanase N, Gaiser B, Johnston H, Stone V (2014) Inflammation and gene expression in the rat lung after instillation of silica nanoparticles: effect of size, dispersion medium and particle surface charge. Toxicol Lett 224(1):147–156
Brzoska M, Langer K, Coester C, Loitsch S, Wagner TOF, Mallinckrodt CV (2004) Incorporation of biodegradable nanoparticles into human airway epithelium cells—in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem Biophys Res Commun 318(2):562–570
Calderon-Garciduenas L, Reed W, Maronpot RR, Henríquez-Roldán C, Delgado-Chavez R, Calderón-Garcidueñas A et al (2004) Brain inflammation and Alzheimer’s-like pathology in individuals exposed to severe air pollution. Toxicol Pathol 32(6):650–658
Campbell MK, Geis I (1995) Biochemistry. Saunders College Publishing, Philadelphia
Campbell A, Oldham M, Becaria A, Bondy SC, Meacher D, Sioutas C et al (2005) Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 26(1):133–140
Casettari L, Vllasaliu D, Castagnino E, Stolnik S, Howdlec S, Illum L (2012) PEGylated chitosan derivatives: synthesis, characterizations and pharmaceutical applications. Prog Polym Sci 37(6):659–685
Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H et al (2007) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104(7):2050–2055
Cenni E, Granchi D, Avnet S, Fotia C, Salerno M, Micieli D et al (2008) Biocompatibility of poly (d, l-lactide-co-glycolide) nanoparticles conjugated with alendronate. Biomaterials 29(10):1400–1411
Chairuangkitti P, Lawanprasert S, Roytrakul S, Aueviriyavit S, Phummiratch D, Kulthong K et al (2013) Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol In Vitro 27(1):330–338
Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique NM, Alving CR et al (2003) Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol 14(9):1430–1437
Chauvierre C, Labarre D, Couvreur P, Vauthier C (2003) Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles. Pharm Res 20(11):1786–1793
Chen HW, Su SF, Chien CT, Lin WH, Yu SL, Chou CC et al (2006) Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J 20(13):2393–2395
Chen C, Cheng YC, Yu CH, Chan SW, Cheung MK, Yu PHF (2008) In vitro cytotoxicity, hemolysis assay, and biodegradation behavior of biodegradable poly(3-hydroxybutyrate)–poly(ethylene glycol)–poly(3-hydroxybutyrate) nanoparticles as potential drug carriers. J Biomed Mater Res A 87(2):290–298
Chithrani BD, Ghazani AA, Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4):662–668
Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N et al (2010) Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 28(12):1300–1303
Contreras-Ruiz L, de la Fuente M, García-Vázquez C, Sáez V, Seijo B, Alonso MJ et al (2010) Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles. Cornea 29(5):550–558
Dailey LA, Jekel N, Fink L, Gessler T, Schmehl T, Wittmar M et al (2006) Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol 215(1):100–108
das Neves J, Michiels J, Ariën KK, Vanham G, Amiji M, Bahia MF, Sarmento B (2012) Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine. Pharm Res 29(6):1468–1484
de Campos AM, Diebold Y, Carvalho ELS, Sánchez A, Alonso MJ (2004) Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 21(5):803–810
De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3(2):133–149
De la Fuente M, Seijo B, Alonso MJ (2008) Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci 49(5):2016–2024
Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 14(11):1568–1573
Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nat Nanotechnol 2(8):469–478
Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L et al (2002) The pulmonary toxicology of ultrafine particles. J Aerosol Med 15(2):213–220
Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2(5):347–360
Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J et al (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114(8):1172–1178
Elsaesser A, Howard CV (2012) Toxicology of nanoparticles. Adv Drug Deliv Rev 64(2):129–137
Enríquez de Salamanca A, Diebold Y, Calonge M, García-Vazquez C, Callejo S, Vila A et al (2006) Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci 47(4):1416–1425
Espuelas MS, Legrand P, Campanero MA, Appel M, Chéron M, Gamazo C et al (2003) Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice. J Antimicrob Chemother 52(3):419–427
Fernandez-Urrusuno R, Fattal E, Porquet D, Feger J, Couvreur P (1995) Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles. Toxicol Appl Pharmacol 130(2):272–279
Fernández-Urrusuno R, Fattal E, Féger J, Couvreur P, Thérond P (1997) Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials 18(6):511–517
Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3):161–171
Fischer HC, Chan WCW (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18(6):565–571
Fischera D, Lib Y, Ahlemeyerc B, Krieglsteinc J, Kissel T (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24(7):1121–1131
Forbes B, Ehrhardt C (2005) Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 60(2):193–205
Frank M, Fries L (1991) The role of complement in inflammation and phagocytosis. Immunol Today 12(9):322–326
Gagliardini E, Conti S, Benigni A, Remuzzi G, Remuzzi A (2010) Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol 21(12):2081–2089
Gajbhiye V, Kumar PV, Tekade RK, Jain NK (2007) Pharmaceutical and biomedical potential of PEGylated dendrimers. Curr Pharm Des 13:415–429
Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 102(27):9469–9474
Gao X, Tao W, Lu W, Zhang Q, Zhang Y, Jiang X, Fu S (2006) Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials 27(18):3482–3490
Garnett MC, Kallinteri P (2006) Nanomedicines and nanotoxicity: some physiological principles. Occup Med 56(5):307–311
Geiser M (2010) Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv 23(4):207–217
Gill S, Löbenberg R, Ku T, Azarmi S, Roa W, Prenner EJ (2007) Nanoparticles: characteristics, mechanisms of action and toxicity in pulmonary drug delivery—a review. J Biomed Nanotechnol 3(2):107–119
Gott RC, Luo Y, Wang Q, Lamp WO (2014) Development of a biopolymer nanoparticle-based method of oral toxicity testing in aquatic invertebrates. Ecotoxicol Environ Saf 104:226–230
Grabowski N, Hillaireau H, Vergnaud J, Santiago LA, Kerdine-Romer S, Pallardy M et al (2013) Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells. Int J Pharm 454(2):686–694
Gref R, Domb A, Quellec P, Blunk T, Muller RH, Verbavatz JM et al (1995) The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 16(2–3):215–233
Hamad I, Hunter AC, Szebeni J, Moghimi SM (2008) Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process. Mol Immunol 46(2):225–232
Hamad I, Al-Hanbali O, Hunter AC, Rutt KJ, Andresen TL, Moghimi SM (2010) Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. ACS Nano 4(11):6629–6638
He C, Hu Y, Yin L, Tang C, Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31(13):3657–3666
Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN (2012) Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomed 7:1851–1863
Huang M, Eugene Khor E, Lim LY (2004) Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 21(2):344–353
Huong TM, Ishida T, Harashima H, Kiwada H (2001) The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig. Int J Pharm 215(1–2):197–205
Ilinskaya AN, Dobrovolskaia MA (2013) Nanoparticles and the blood coagulation system. Part II: safety concerns. Nanomedicine 8(6):969–981
Illum L, Davis SS, Muller RH, Mak E, West P (1987) The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer-Poloxamine 908. Life Sci 40(4):367–374
Jain AK, Swarnakar NK, Godugu C, Singh RP, Jain S (2011) The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 32(2):503–515
Johnson RJ (2004) The complement system. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (eds) Biomaterials science: an introduction to materials in medicine. Elsevier Academic Press, Amsterdam, pp 318–328
Kazimirova A, Magdolenova Z, Barancokova M, Staruchova M, Volkovova K, Dusinska M (2012) Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by the comet assay and the cytokinesis-block micronucleus assay. Mutat Res 748(1–2):42–47
Keck CM, Muller RH (2013) Nanotoxicological classification system (NCS)—a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. Eur J Pharm Biopharm 84(3):445–448
Kemper C, Atkinson JP, Hourcade DE (2010) Properdin: emerging roles of a pattern recognition molecule. Annu Rev Immunol 28:131–155
Kim KJ, Borok Z, Crandall ED (2001) A useful in vitro model for transport studies of alveolar epithelial barrier. Pharm Res 18(3):253–255
Klesing J, Wiehe A, Gitter B, Grafe S, Epple M (2010) Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy. J Mater Sci Mater Med 21(3):887–892
Knopf PM, Rivera DS, Hai SH, McMurry J, Martin W, De Groot AS (2008) Novel function of complement C3d as an autologous helper T-cell target. Immunol Cell Biol 86(3):221–225
Kompella UB, Amrite AC, Pacha Ravi R, Durazo SA (2013) Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res 36:172–198
Koziara JM, Oh JJ, Akers WS, Ferraris SP, Mumper RJ (2005) Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res 22(11):1821–1828
Kreyling WG, Semmler-Behnke M, Möller W (2006) Health implications of nanoparticles. J Nanopart Res 8:543–562
Labarre D, Vauthier C, Chauvierre C, Petri B, Müller R, Chehimi MM (2005) Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 26(24):5075–5084
Lanone S, Boczkowski J (2006) Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med 6(6):651–663
Lee DW, Powers K, Baney R (2004) Physicochemical properties and blood compatibility of acylated chitosan nanoparticles. Carbohydr Polym 58(4):371–377
Lekshmi UM, Kishore N, Reddy PN (2011) Sub-acute toxicity assessment of glipizide engineered polymeric nanoparticles. J Biomed Nanotechnol 7(4):578–589
Lemarchand C, Gref R, Passirani C, Garcion E, Petri B, Muller R et al (2006) Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials 27(1):108–118
Lherm C, Müller RH, Puisieux F, Couvreur P (1992) Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int J Pharm 84(1):13–22
Li X, Radomski A, Corrigan OI, Tajber L, Menezes FS, Endter S et al (2009) Platelet compatibility of PLGA, chitosan and PLGA–chitosan nanoparticles. Nanomedicine 4(7):735–746
Liao L, Zhang M, Liu H, Zhang X, Xie Z, Zhang Z et al (2014) Subchronic toxicity and immunotoxicity of MeO-PEG-poly(d, l-lactic-co-glycolic acid)-PEG-OMe triblock copolymer nanoparticles delivered intravenously into rats. Nanotechnology 25(24):245705
Lira MC, Santos-Magalhães NS, Nicolas V, Marsaud V, Silva MP, Ponchel G, Vauthier C (2011) Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles. Eur J Pharm Biopharm 79(1):162–170
Liu Y, Li W, Lao F, Liu Y, Wang L, Bai R et al (2011a) Intracellular dynamics of cationic and anionic polystyrene nanoparticles without direct interaction with mitotic spindle and chromosomes. Biomaterials 32(32):8291–8303
Liu Q, Shao X, Chen J, Shen Y, Feng C, Gao X et al (2011b) In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain. Toxicol Appl Pharmacol 251(1):79–84
Lu JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q et al (2009) Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 9(4):325–341
Luo R, Neu B, Venkatraman SS (2012) Surface functionalization of nanoparticles to control cell interactions and drug release. Small 8(16):2585–2594
Luo Y, Teng Z, Wang TT, Wang Q (2013) Cellular uptake and transport of zein nanoparticles: effects of sodium caseinate. J Agric Food Chem 61(31):7621–7629
Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA (2007) The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 134–135:167–174
Lynch I, Salvati A, Dawson KA (2009) Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol 4(9):546–547
Maya S, Indulekha S, Sukhithasri V, Smitha KT, Nair SV, Jayakumar R et al (2012) Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. Int J Biol Macromol 51(4):392–399
Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW (2007) Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150(5):552–558
Merodio M, Irache JM, Valamanesh F, Mirshahi M (2002) Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials 23(7):1587–1594
Mitchell RN (2004) Innate and adaptive immunity: the immune response to foreign materials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (eds) Biomaterials science: an introduction to materials in medicine. Elsevier Academic Press, Amsterdam, pp 304–318
Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN (2007) Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release 119(1):77–85
Mo Y, Barnett ME, Takemoto D, Davidson H, Kompella UB (2007) Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene. Mol Vis 13:746–757
Moghimi SM, Hunter C, Dadswell CM, Savay S, Alving C, Szebeni J (2004) Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels. Biochim Biophys Acta 1689(2):103–113
Moghimi SM, Andersen AJ, Hashem SH, Lettiero B, Ahmadvand D, Hunter AC et al (2010) Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead. J Control Release 146(2):175–181
Mohammadi Ghalaei P, Varshosaz J, Sadeghi Aliabadi H (2014) Evaluating cytotoxicity of hyaluronate targeted solid lipid nanoparticles of etoposide on SK-OV-3 cells. J Drug Deliv 2014:746325
Moulari B, Béduneau A, Pellequer Y, Lamprecht A (2014) Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis. J Control Release 188:9–17
Muller RH, Lherm C, Herbort J, Couvreur P (1990) In vitro model for the degradation of alkylcyanoacrylate nanoparticles. Biomaterials 11(8):590–595
Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(d, l-lactide-co-glycolide) and its derivatives. J Control Release 125(3):193–209
Mura S, Hillaireau H, Nicolas J, Le Droumaguet B, Gueutin C, Zanna S et al (2011) Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomed 6:2591–2605
Nagayama S, Ogawara K, Fukuoka Y, Higaki K, Kimura T (2007) Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm 342(1–2):215–221
Nair LS, Laurencin CT (2007) Biodegradable polymers as biomaterials. Prog Polym Sci 32:762–798
Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311(5761):622–627
Nemmar A, Hoylaerts MF, Hoet PH, Nemery B (2004) Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett 149(1–3):243–253
Nemmar A, Dhanasekaran S, Yasin J, Ba-Omar H, Fahim MA, Kazzam EE et al (2009) Evaluation of the direct systemic and cardiopulmonary effects of diesel particles in spontaneously hypertensive rats. Toxicology 262(1):50–56
Oberdörster E (2004) Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 112(10):1058–1062
Oberdorster G, Oberdorster E, Oberdorster J (2005a) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839
Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K et al (2005b) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
Oberdorster G, Stone V, Donaldson K (2007) Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1(1):2–25
Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A et al (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16(6–7):437–445
Ojer P, de Cerain AL, Areses P, Penuelas I, Irache JM (2012) Toxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery. Pharm Res 29(9):2615–2627
Ojer P, Neutsch L, Gabor F, Irache JM, Lopez de Cerain A (2013) Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery. J Biomed Nanotechnol 9(11):1891–1903
Ojer P, Iglesias T, Azqueta A, Irache JM, López de Cerain A (2015) Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs. Eur J Pharm Biopharm 97(Pt A):206–217
Panagi Z, Beletsi A, Evangelatos G, Livaniou E, Ithakissios DS, Avgoustakis K (2001) Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm 221(1–2):143–152
Pandita D, Kumar S, Lather V (2015) Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospective. Drug Discov Today 20(1):95–104
Panessa-Warren BJ, Maye MM, Warren JB, Crosson KM (2009) Single walled carbon nanotube reactivity and cytotoxicity following extended aqueous exposure. Environ Pollut 157(4):1140–1151
Pathak D, Kumar P, Kuppusamy G, Gupta A, Kamble B, Wadhwani A (2014) Physicochemical characterization and toxicological evaluation of plant-based anionic polymers and their nanoparticulated system for ocular delivery. Nanotoxicology 8(8):843–855
Peracchia MT, Fattal E, Desmaele D, Besnard M, Noel JP, Gormis JM et al (1999) Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release 60(1):121–128
Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM (2006) Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90(2):296–303
Powers KW, Palazuelos M, Moudgil BM, Roberts SM (2007) Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 1(1):42–51
Prego C, Torres D, Fernandez-Megia E, Novoa-Carballal R, Quiñoá E, Alonso MJ (2006) Chitosan–PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree. J Control Release 111(3):299–308
Prieto E, Puente B, Uixera A, Garcia de Jalon JA, Perez S, Pablo L et al (2012) Gantrez AN nanoparticles for ocular delivery of memantine: in vitro release evaluation in albino rabbits. Ophthalmic Res 48(3):109–117
Prow TW, Bhutto I, Kim SY, Grebe R, Merges C, McLeod DS et al (2008) Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine 4(4):340–349
Qi L, Xu Z, Jiang X, Li Y, Wang M (2005) Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg Med Chem Lett 15(5):1397–1399
Qi J, Yao P, He F, Yu C, Huang C (2010) Nanoparticles with dextran/chitosan shell and BSA/chitosan core—doxorubicin loading and delivery. Int J Pharm 393(1–2):176–184
Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T et al (2005) Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146(6):882–893
Reasor MJ, Hastings KL, Ulrich RG (2006) Drug-induced phospholipidosis: issues and future directions. Expert Opin Drug Saf 5(4):567–583
Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O’Neil CP et al (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25(10):1159–1164
Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clarthrin- and caveolae-mediated endocytosis. Biochem J 377(Pt 1):159–169
Rekha MR, Sharma CP (2009) Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release 135(2):144–151
Ren WH, Chang J, Yan CH, Qian XM, Long LX, He B et al (2010) Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma. J Mater Sci Mater Med 21(9):2673–2681
Roser M, Fischer D, Kissel T (1998) Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46(3):255–263
Sahoo SK, Panyam J, Prabha S, Labhasetwar V (2002) Residual polyvinyl alcohol associated with poly (d, l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82(1):105–114
Schmid O, Möller W, Semmler-Behnke M, Ferron GA, Karg E, Lipka J et al (2009) Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers 14(Suppl 1):67–73
Schmitz G, Grandl M (2009) Endolysossomal phospholipidosis and cytosolic lipid droplet storage and release in macrophages. Biochim Biophys Acta 1791(6):524–539
Semete B, Booysen L, Lemmer Y, Kalombo L, Katata L, Verschoor J et al (2010a) In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine 6(5):662–671
Semete B, Booysen LI, Kalombo L, Venter JD, Katata L, Ramalapa B et al (2010b) In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. Toxicol Appl Pharmacol 249(2):158–165
Severino P, Andreani T, Jager A, Chaud W, Santana MH, Silva AM et al (2014) Solid lipid nanoparticles for hydrophilic biotech drugs: optimization and cell viability studies (Caco-2 & HEPG-2 cell lines). Eur J Med Chem 23(81):28–34
Seyfoddin A, Shaw J, Al-Kassas R (2010) Solid lipid nanoparticles for ocular drug delivery. Drug Deliv 17(7):467–489
Shah NB, Vercellotti GM, White JG, Fegan A, Wagner CR, Bischof JC (2012) Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties. Mol Pharm 9(8):2146–2155
Shao X, Liu Q, Zhang C, Zheng X, Chen J, Zha Y et al (2013) Concanavalin A-conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal drug delivery to the cervical lymph nodes. J Microencapsul 30(8):780–786
Shrestha N, Shahbazi MA, Araujo F, Zhang H, Makila EM, Kauppila J et al (2014) Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers. Biomaterials 35(25):7172–7179
Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW (2009) In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30(12):2329–2339
Stuart D, Löbenberg R, Ku T, Azarmi S, Ely L, Roa W et al (2006) Biophysical investigation of nanoparticle interactions with lung surfactant model systems. J Biomed Nanotechnol 2(3–4):245–252
Szebeni J (2005) Complement activation-related pseudoallergy: a new class of drug-induced immune toxicity. Toxicology 216(2–3):106–121
Szebeni J, Muggia F, Gabizon A, Barenholz Y (2011) Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Adv Drug Deliv Rev 63(12):1020–1030
Tan ML, Choong PF, Dass CR (2010) Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides 31(1):184–193
Tseng YC, Tabata Y, Hyon SH, Ikada Y (1990a) In vitro toxicity test of 2-cyanoacrylate polymers by cell culture method. J Biomed Mater Res 24(10):1355–1367
Tseng YC, Hyon SH, Ikada Y (1990b) Modification of the synthesis and investigation of properties for 2-cyanoacrylates. Biomaterials 11(1):73–79
Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P (2003) Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 55(4):519–548
Vauthier C, Lindner P, Cabane B (2009) Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona. Colloids Surf B Biointerfaces 69(2):207–215
Vauthier C, Persson B, Lindner P, Cabane B (2011) Protein adsorption and complement activation for di-block copolymer nanoparticles. Biomaterials 32(6):1646–1656
Verma A, Stellacci F (2010) Effect of surface properties on nanoparticle-cell interactions. Small 6(1):12–21
Vittaz M, Bazile D, Spenlehauer G, Verrecchia T, Veillard M, Puisieux F, Labarre D (1996) Effect of PEO surface density on long circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials 17(16):1575–1581
Vonarbourg A, Passirani C, Saulnier P, Simard P, Leroux JC, Benoit JP (2006) Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A 78(3):620–628
Weiss CK, Lorenz MR, Landfester K, Mailänder V (2007) Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion. Macromol Biosci 7(7):883–896
Wen Z, Yan Z, He R, Pang Z, Guo L, Qian Y et al (2011) Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration. Drug Deliv 18(8):555–561
Williams D (2003) Revisiting the definition of biocompatibility. Med Device Technol 14(8):10–13
Wing KY, Feng SS (2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26(15):2713–2722
Xu L, Xu X, Chen H, Li X (2013) Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye. Colloids Surf B Biointerfaces 112:30–34
Yacobi NR, Malmstadt N, Fazlollahi F, DeMaio L, Marchelletta R, Hamm-Alvarez SF et al (2010) Mechanisms of alveolar epithelial translocation of a defined population of nanoparticles. Am J Respir Cell Mol Biol 42(5):604–614
Yadav AK, Mishra P, Jain S, Mishra P, Mishra AK, Agrawal GP (2008) Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. J Drug Target 16(6):464–478
Yan Y, Gordon WM, Wang DY (2013) Nasal epithelial repair and remodeling in physical injury, infection, and inflammatory diseases. Curr Opin Otolaryngol Head Neck Surg 21(3):263–270
Yeh TH, Hsu LW, Tseng MT, Lee PL, Sonaje K, Ho YC et al (2011) Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials 32(26):6164–6173
Yin L, Ding J, He C, Cui L, Tang C et al (2009) Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 30(29):5691–5700
Yu T, Malugin A, Ghandehari H (2011) The impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 5(7):5717–5728
Yu M, Huang S, Yu KJ, Clyne AM (2012) Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int J Mol Sci 13(5):5554–5570
Zaki NM, Hafez MM (2012) Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium. AAPS PharmSciTech 13(2):411–421
Zandanel C, Vauthier C (2012) Poly(isobutylcyanoacrylate) nanoparticles decorated with chitosan: effect of conformation of chitosan chains at the surface on complement activation properties. J Colloid Sci Biotechnol 1:68–81
Zauner W, Farrow NA, Haines AM (2001) In vitro uptake of polystyrene micro spheres: effect of particle size, cell line and cell density. J Control Release 71(1):39–51
Zhang Z, Feng SS (2006) The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)–tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 27(21):4025–4033
Zhang C, Qu G, Sun Y, Yang T, Yao Z, Shen W et al (2008) Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs. Eur J Pharm Sci 33(4–5):415–423
Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J (2012) Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Eur J Pharm Sci 45(5):632–638
Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, Lin VS (2011) Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 5(2):1366–1375
Zolnik BS, González-Fernández A, Sadrieh N, Dobrovolskaia MA (2010) Nanoparticles and the immune system. Endocrinology 151(2):458–465
Acknowledgments
The authors wish to thank for support by the European Community´s Seventh Framework Programme via the large project “Alexander” (FP7-2011-NMP-280761).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Irache, J.M., Martín-Arbella, N., Ojer, P., Azqueta, A., Lopez de Cerain, A. (2016). Toxicological Aspects of Polymer Nanoparticles. In: Vauthier, C., Ponchel, G. (eds) Polymer Nanoparticles for Nanomedicines. Springer, Cham. https://doi.org/10.1007/978-3-319-41421-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-41421-8_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41419-5
Online ISBN: 978-3-319-41421-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)